Stay updated on Pembrolizumab for Mycosis Fungoides Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Mycosis Fungoides Clinical Trial page.

Latest updates to the Pembrolizumab for Mycosis Fungoides Clinical Trial page
- CheckyesterdayChange DetectedPage revision updated from v3.0.1 to v3.0.2, signaling a new release; 'Back to Top' was removed as a minor UI change.SummaryDifference0.1%
- Check8 days agoChange DetectedThe page has been updated to reflect a new version, v3.0.1, indicating a recent revision. The previous version, v3.0.0, has been removed from the page.SummaryDifference0.2%
- Check15 days agoChange DetectedThe web page has been updated to include new information about mycosis fungoides and Sézary syndrome, including the mSWAT scoring system and the addition of specific dates and facility details, while removing some previous location-related terms and outdated references.SummaryDifference3%
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe webpage has been updated to reflect new results and timelines for a clinical trial involving Pembrolizumab in treating Mycosis Fungoides, with significant changes in the reporting dates and the duration of various response metrics.SummaryDifference19%
- Check37 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check44 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.8%
Stay in the know with updates to Pembrolizumab for Mycosis Fungoides Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Mycosis Fungoides Clinical Trial page.